Sanna Bastiano
CIK 0001829069
EVP, Cell & Genetic TherapiesDirector
Filings
26
Latest Aug 16, 2023
Issuers covered
2
Showing
26 of 26
Page 1
Track record
46 of 46 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 46 | 52% | +0.0% | +0.3% | +14.8% | -13.2% |
| 90 days | 46 | 2% | -7.8% | -6.1% | +0.1% | -20.2% |
| 180 days | 46 | 0% | -12.3% | -10.6% | -3.2% | -20.4% |
| 365 days | 46 | 0% | -26.3% | -28.3% | -15.5% | -39.2% |
Issuers
Companies where Sanna Bastiano has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc / Ma | 23 | May 9, 2023 |
| ACET | Adicet Bio, Inc. | 3 | Aug 16, 2023 |
All filings
26 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|